Literature DB >> 4853253

Monoclonal gammopathy penicillamine-induced polymyositis and systemic sclerosis.

M Nishikai, Y Funatsu, M Homma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4853253

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  5 in total

1.  Serum immunogloblin levels in myasthenia gravis, polymyositis, and dermatomyositis.

Authors:  R P Lisak; B Zweiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-01       Impact factor: 10.154

2.  An Update on the Treatment of the Cutaneous Manifestations of Systemic Sclerosis: The Dermatologist's Point of View.

Authors:  Magalys Vitiello; Adriana Abuchar; Néstor Santana; Luis Dehesa; Francisco A Kerdel
Journal:  J Clin Aesthet Dermatol       Date:  2012-07

Review 3.  Immunological features of polymyositis/dermatomyositis.

Authors:  W M Behan; P O Behan
Journal:  Springer Semin Immunopathol       Date:  1985

4.  Dermatomyositis complicating penicillamine treatment.

Authors:  L Fernandes; D R Swinson; E B Hamilton
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

5.  Dermatomyositis induced by penicillamine.

Authors:  F Wojnarowska
Journal:  J R Soc Med       Date:  1980-12       Impact factor: 18.000
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.